Clinical Trial Update: Avatrombopag Combined With IST as First-line Treatment for SAA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring avatrombopag plus IST as first-line therapy for severe aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Severe Aplastic Anemia | Phase 2 | Status: UNKNOWN